Effects of Osteopathic Manipulative Treatment and Bio Electro-Magnetic Regulation Therapy on Low Back Pain in Adults.
1 other identifier
interventional
40
1 country
1
Brief Summary
It is clear that low back pain (LBP) is a major challenge in our society, which can lead to severe disability in many individuals. Although there are several different treatments and approaches to help individuals with LBP, the number affected by this condition has been steadily increasing. OMT has been shown to be helpful in the treatment of LBP. In fact, the use of OMT has been shown to increase mobility of the lumbar myofascial tissues, visceral motion and decrease pain in patients with LBP. Bio Electro-Magnetic Regulation (BEMER) Therapy is a therapeutic modality that deploys a biorhythmically defined stimulus through a Pulsed Electromagnetic Field (PEMF), which leads to an increase in blood flow. The positive effects of BEMER on the circulation has been shown to result in significant increases in arteriovenous oxygen difference, number of open capillaries, arteriolar and venular flow volume, and flow rate of red blood cells in the microvasculature. Therefore, BEMER can potentially be used in the treatment of LBP by improving microcirculation in muscular tissue. In fact, BEMER with physiotherapy showed reductions in pain and fatigue acutely in patients with chronic low back pain. A systemic review of randomized controlled trials that investigated whether PEMF was effective in low back pain showed there was decrease in pain intensity and improved functionality in individuals with different low back pain conditions. Therefore, it is plausible that the combination of OMT and BEMER therapy may help increase circulation to myofascial structures that influence low back restriction and pain. The purpose of this study is to investigate the individual and combined effects of OMT and BEMER therapy on low back pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 13, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 9, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 9, 2019
CompletedFirst Submitted
Initial submission to the registry
January 6, 2021
CompletedFirst Posted
Study publicly available on registry
January 11, 2021
CompletedResults Posted
Study results publicly available
April 26, 2023
CompletedNovember 18, 2023
April 1, 2023
12 months
January 6, 2021
March 8, 2023
November 14, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Low Back Pain Rating Visual Analog Scale
Assessed by questionnaire rating, compared with pre-intervention rating Visual Analog Scale (VAS). Score ranges 0-100. Minimum score=0 (no pain), Maximum score=100 (worst pain ever felt). Lower scores is better as it reflect lower pain
Within 1 week of completion of 3-week intervention period
Low Back Pain Rating Oswestry Low Back Pain Questionnaire
Assessed by questionnaire rating, compared with pre-intervention rating Oswestry low back pain questionnaire: Scores range 0-50. 0-4 indicating no disability; 5-14 indicating minimal disability; 15-24 moderate disability; 25-34 severe disability; 35-50 complete disability. Lower scores is better as it reflect lower pain
Within 1 week of completion of 3-week intervention period
Quality of Life Rating Short Form 12-item (SF-12) Health Survey
Assessed by questionnaire rating, compared with pre-intervention rating Short form 12-item (SF-12) health survey. Scores range 0%-100%. Score of 0 (minimum) no pain. Score of 100 (maximum) lot of pain. Lower scores is better as it reflect lower pain
Within 1 week of completion of 3-week intervention period
Study Arms (4)
Bio Electro-Magnetic Regulation (BEMER) Therapy
EXPERIMENTALSubjects in the BEMER group received treatment 5 times per week for a period of 3 weeks.
OMT (Osteopathic Manipulative Treatment)
ACTIVE COMPARATOREach subject in the OMT group received treatment 3 times per week for a period of 3 weeks.
BEMER + OMT
EXPERIMENTALEach subject in the BEMER + OMT group received treatment 3 times per week for a period of 3 weeks.
Control
SHAM COMPARATORFinally, subjects in the Placebo group will receive the light touch and BEMER sham treatments at same intervals as the corresponding experimental groups.
Interventions
BEMER is a therapeutic modality that deploys a biorhythmically defined stimulus through Pulsed Electromagnetic Field (PEMF). This stimulus has a targeted effect on the microvasculature, and the primary effect is an improvement in tissue microcirculation. The positive effects of vasomotion on the microcirculation has been shown to result in significant increases in arteriovenous oxygen difference, number of open capillaries, arteriolar and venular flow volume, and flow rate of red blood cells in the microvasculature. Therefore, BEMER can potentially be used in the treatment of LBP by improving microcirculation in muscular tissue.
i. OMT Myofascial release (MFR), soft tissue (ST) release, muscle energy (ME), counterstrain (CS), and balanced ligamentous tension (BLT) technique.
Treaters will place their hands lightly on the subject's lumbar paraspinal muscles in the supine and prone positions in the same area as where one would place your hands for lumbar MFR technique for the same amount of time as it would take to perform MFR in this area (approximately 5 minutes). However, no lifting or action will be done. In addition, the subject will lie down on the BEMER mat (as they would do during a BEMER session), but the device will not be activated.
Eligibility Criteria
You may qualify if:
- LECOM-Bradenton faculty, staff and Students currently enrolled in LECOM-Bradenton's osteopathic medical program, pharmacy program, dental program, and master's program
- Currently experiencing low back pain.
You may not qualify if:
- Unable to provide informed consent
- Currently pregnant
- Medical history of current psychiatric conditions
- Skin disorders or open wounds precluding skin contact
- Fasciitis of fascial tears
- Myositis
- Neurological symptoms such as numbness, tingling, weakness in lower extremities
- Neoplasia
- Cancer
- Bone fracture, osteomyelitis, or osteoporosis,
- Coagulation problem
- Deep vein thrombosis
- Adrenal diseases/syndromes,
- Acute upper or lower respiratory infection
- Immunosuppressive syndromes
- +11 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
LECOM-Bradenton
Bradenton, Florida, 34211, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Santiago Lorenzo
- Organization
- LECOM
Study Officials
- PRINCIPAL INVESTIGATOR
Santiago Lorenzo, PhD
Lake Erie College of Osteopathic Medicine
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Physiology
Study Record Dates
First Submitted
January 6, 2021
First Posted
January 11, 2021
Study Start
September 13, 2018
Primary Completion
September 9, 2019
Study Completion
September 9, 2019
Last Updated
November 18, 2023
Results First Posted
April 26, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will not share